|
Sign In to gain access to subscriptions and/or personal tools.
|
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis
Basil Sharrack
Department of Clinical Neuroscience, Hodgkin Building, Guy's, King's and St. Thomas' School of Medicine, Guy's Hospital, London, SE1 9RT, UK
Richard AC Hughes
Department of Clinical Neuroscience, Hodgkin Building, Guy's, King's and St. Thomas' School of Medicine, Guy's Hospital, London, SE1 9RT, UK
A postal survey showed that the majority of 49 leading international neurologists involved with multiple sclerosis research felt that currently existing outcome measures for this illness were inadequate, and that there was a need for a new measure which should be patient orientated, multidimensional, and not biased towards any particular disability. The Guy's Neurological Disability Scale (GNDS) was subsequently devised as a simple and user-friendly clinical disability scale capable of embracing the whole range of disabilities which could be encountered in the course of multiple sclerosis. It has 12 separate categories which include cognition, mood, vision, speech, swallowing, upper limb function, lower limb function, bladder function, bowel function, sexual function, fatigue, and `others'. The GNDS was found to be acceptable to neurologists and patients, reliable, responsive, and valid as a measure of disability. The scale was also found to be valid when applied by non-neurologists, over the phone, or via a postal questionnaire.
Key Words: The Guy's Neurological Disability Scale • GNDS • multiple sclerosis • disability
Multiple Sclerosis, Vol. 5, No. 4,
223-233 (1999)
DOI: 10.1177/135245859900500406
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
S Kopke, J Kasper, I Muhlhauser, M Nubling, and C Heesen
Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial
Multiple Sclerosis,
January 1, 2009;
15(1):
96 - 104.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C Heesen, J Bohm, C Reich, J Kasper, M Goebel, and S. Gold
Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable
Multiple Sclerosis,
August 1, 2008;
14(7):
988 - 991.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Kos, M. Duportail, M. D'hooghe, G. Nagels, and E. Kerckhofs
Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial
Multiple Sclerosis,
September 1, 2007;
13(8):
996 - 1003.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Costelloe, K. O'Rourke, H. Kearney, C. McGuigan, L. Gribbin, M. Duggan, L. Daly, N. Tubridy, and M. Hutchinson
The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)
J. Neurol. Neurosurg. Psychiatry,
August 1, 2007;
78(8):
841 - 844.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Piepers, R. Van den Berg-Vos, W-L. Van der Pol, H. Franssen, J. Wokke, and L. Van den Berg
Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial
Brain,
August 1, 2007;
130(8):
2004 - 2010.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Edmonds, B. Vivat, R. Burman, E. Silber, and I.J. Higginson
`Fighting for everything': service experiences of people severely affected by multiple sclerosis
Multiple Sclerosis,
June 1, 2007;
13(5):
660 - 667.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Edmonds, B. Vivat, R. Burman, E. Silber, and I. J Higginson
Loss and change: experiences of people severely affected by multiple sclerosis
Palliative Medicine,
March 1, 2007;
21(2):
101 - 107.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J J Kragt, J M Nielsen, F A. van der Linden, B M. Uitdehaag, and C H Polman
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Multiple Sclerosis,
November 1, 2006;
12(6):
782 - 786.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. de Groot, H. Beckerman, B. M. J. Uitdehaag, H. C. W. de Vet, G. J. Lankhorst, C. H. Polman, and L. M. Bouter
The usefulness of evaluative outcome measures in patients with multiple sclerosis
Brain,
October 1, 2006;
129(10):
2648 - 2659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J J Kragt, F A. van der Linden, J M Nielsen, B M. Uitdehaag, and C H Polman
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis
Multiple Sclerosis,
September 1, 2006;
12(5):
594 - 598.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S J Crenshaw, T D Royer, J G Richards, and D J Hudson
Gait variability in people with multiple sclerosis
Multiple Sclerosis,
September 1, 2006;
12(5):
613 - 619.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M S Chong, K Wolff, K Wise, C Tanton, A Winstock, and E Silber
Cannabis use in patients with multiple sclerosis
Multiple Sclerosis,
September 1, 2006;
12(5):
646 - 651.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M S. Deloire, M C Bonnet, E Salort, Y Arimone, M Boudineau, K G Petry, and B Brochet
How to detect cognitive dysfunction at early stages of multiple sclerosis?
Multiple Sclerosis,
August 1, 2006;
12(4):
445 - 452.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R F Brown, C C Tennant, M Sharrock, S Hodgkinson, S M Dunn, and J D Pollard
Relationship between stress and relapse in multiple sclerosis: part I. Important features
Multiple Sclerosis,
August 1, 2006;
12(4):
453 - 464.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B R Stanton, F Barnes, and E Silber
Sleep and fatigue in multiple sclerosis
Multiple Sclerosis,
August 1, 2006;
12(4):
481 - 486.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R C Graham and R A C Hughes
A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale
J. Neurol. Neurosurg. Psychiatry,
August 1, 2006;
77(8):
973 - 976.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L K Storr, P S Sorensen, and M Ravnborg
The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients
Multiple Sclerosis,
April 1, 2006;
12(2):
235 - 242.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. J. Rog, T. J. Nurmikko, T. Friede, and C. A. Young
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Neurology,
September 27, 2005;
65(6):
812 - 819.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. C. Mohr, S. L. Hart, L. Julian, C. Catledge, L. Honos-Webb, L. Vella, and E. T. Tasch
Telephone-Administered Psychotherapy for Depression
Arch Gen Psychiatry,
September 1, 2005;
62(9):
1007 - 1014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M S A Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, et al.
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
April 1, 2005;
76(4):
519 - 526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Kileff and A Ashburn
A pilot study of the effect of aerobic exercise on people with moderate disability multiple sclerosis
Clinical Rehabilitation,
February 1, 2005;
19(2):
165 - 169.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. J. Kragt, E. L.J. Hoogervorst, B. M.J. Uitdehaag, and C. H. Polman
Relation between objective and subjective measures of bladder dysfunction in multiple sclerosis
Neurology,
November 9, 2004;
63(9):
1716 - 1718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E L. Hoogervorst, J N. Zwemmer, B Jelles, C H Polman, and B M. Uitdehaag
Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability
Multiple Sclerosis,
October 1, 2004;
10(5):
569 - 574.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O.R. Pearson, M.E. Busse, R.W.M. van Deursen, and C.M. Wiles
Quantification of walking mobility in neurological disorders
QJM,
August 1, 2004;
97(8):
463 - 475.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C McGuigan and M Hutchinson
The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure
J. Neurol. Neurosurg. Psychiatry,
February 1, 2004;
75(2):
266 - 269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Hobart, N Kalkers, F Barkhof, B Uitdehaag, C Polman, and A Thompson
Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional C omposite
Multiple Sclerosis,
February 1, 2004;
10(1):
41 - 46.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E L. Hoogervorst, N F Kalkers, G R Cutter, B M. Uitdehaag, and C H Polman
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional C omposite
Multiple Sclerosis,
February 1, 2004;
10(1):
55 - 60.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J Craig, C A Young, M Ennis, G Baker, and M Boggild
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment
J. Neurol. Neurosurg. Psychiatry,
September 1, 2003;
74(9):
1225 - 1230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J Groom, N. B Lincoln, V. M Francis, and T. F Stephan
Assessing mood in patients with multiple sclerosis
Clinical Rehabilitation,
August 1, 2003;
17(8):
847 - 857.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L P McKeown, A P Porter-Armstrong, and G D Baxter
The needs and experiences of caregivers of individuals with multiple sclerosis: a systematic review
Clinical Rehabilitation,
March 1, 2003;
17(3):
234 - 248.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. C. Hobart, A. Riazi, D. L. Lamping, R. Fitzpatrick, and A. J. Thompson
Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12)
Neurology,
January 14, 2003;
60(1):
31 - 36.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E L J Hoogervorst, P de Jonge, B Jelles, F J Huyse, I Heeres, H M van der Ploeg, B M J Uitdehaag, and C H Polman
The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment
J. Neurol. Neurosurg. Psychiatry,
January 1, 2003;
74(1):
20 - 24.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J Thompson
Developing clinical outcome measures in multiple sclerosis: an evolving process
Multiple Sclerosis,
October 1, 2002;
8(5):
357 - 358.
[PDF]
|
|
|
|
|
|
|
C R Nicholl, N B Lincoln, and E D Playford
The reliability and validity of the Nottingham Extended Activities of Daily Living Scale in patients with multiple sclerosis
Multiple Sclerosis,
October 1, 2002;
8(5):
372 - 376.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D T Wade, C A Young, K R Chaudhuri, and D L W Davidson
A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
September 1, 2002;
73(3):
246 - 249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Van den Berg-Vos, H. Franssen, J. H. J. Wokke, and L. H. V. d. Berg
Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment
Brain,
August 1, 2002;
125(8):
1875 - 1886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N B Lincoln, A Dent, J Harding, N Weyman, C Nicholl, L D Blumhardt, and E D Playford
Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
January 1, 2002;
72(1):
93 - 98.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Rossier and D. T Wade
The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity
Clinical Rehabilitation,
January 1, 2002;
16(1):
75 - 95.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E L. Hoogervorst, N F Kalkers, L M. van Winsen, B M. Uitdehaag, and C H Polman
Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis
Multiple Sclerosis,
October 1, 2001;
7(5):
335 - 339.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. R Nicholl, N. B Lincoln, V. M Francis, and T. F Stephan
Assessment of emotional problems in people with multiple sclerosis
Clinical Rehabilitation,
June 1, 2001;
15(6):
657 - 668.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Hobart, D. Lamping, R. Fitzpatrick, A. Riazi, and A. Thompson
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
Brain,
May 1, 2001;
124(5):
962 - 973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E.L.J. Hoogervorst, L.M.L. van Winsen, M.J. Eikelenboom, N.F. Kalkers, B.M.J. Uitdehaag, and C.H. Polman
Comparisons of patient self-report, neurologic examination, and functional impairment in MS
Neurology,
April 10, 2001;
56(7):
934 - 937.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L D Blumhardt, B J. Vermeij, M Amato, O Andersen, G Edan, O Fernandez, M Filippi, J Haas, O R Hommes, and P Rieckmann
A quality network model for the daily care of multiple sclerosis
Multiple Sclerosis,
August 1, 2000;
6(4):
231 - 236.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Liu and L. D Blumhardt
Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts
J. Neurol. Neurosurg. Psychiatry,
April 1, 2000;
68(4):
450 - 457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
